Joanie Pinard, MD | |
221 Longwood Ave, Boston, MA 02115-5804 | |
(617) 264-5920 | |
Not Available |
Full Name | Joanie Pinard |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 221 Longwood Ave, Boston, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346692472 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 266233 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joanie Pinard, MD 221 Longwood Ave, Boston, MA 02115-5804 Ph: (617) 264-5920 | Joanie Pinard, MD 221 Longwood Ave, Boston, MA 02115-5804 Ph: (617) 264-5920 |
News Archive
Influenza pandemics have been among the most unpredictable and devastating natural disasters, but discussions about them are usually confined to specialists. This book makes fascinating reading for anyone who wants to understand the context of pandemics but may have been deterred by the technical detail.
The Caregiver Expo2010, presented by Alternatives for Seniors, will be held 9:30 a.m. to 3 p.m. Saturday, November 13, 2010 at the Doubletree Hotel, in Oak Brook, Illinois. The free event is being held in conjunction with the National Family Caregiver Month observed every November. National Family Caregiver Month is a nationally recognized time to focus attention on the more than 65 million family caregivers who provide 80% of our nation's long term care services.
Researchers at the University of Reading are setting up a clinical database of healthy older people willing to take part in a wide range of important research projects which could help shape the future of healthcare for senior citizens.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV- (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. INTUNIV, a once-daily formulation of guanfacine, is the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD.
› Verified 6 days ago
Erica Dommasch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Shapiro 2, Boston, MA 02215 Phone: 617-667-3753 | |
Dr. Chantal Louise Cotter, MB BCH BAO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
Dr. John J Croke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Debjani Sahni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Joseph C Kvedar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Staniford St, Suite 200, Boston, MA 02114 Phone: 617-726-2914 Fax: 617-724-2135 | |
Ryan Char Kelm, Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St # 250, Boston, MA 02114 Phone: 617-724-6960 | |
Dr. David Attar Hashemi, MD, MBA Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St, Boston, MA 02114 Phone: 617-726-2914 |